A Role for Clusterin in Exfoliation Syndrome and Exfoliation Glaucoma?
- PMID: 29965900
- PMCID: PMC8035929
- DOI: 10.1097/IJG.0000000000000916
A Role for Clusterin in Exfoliation Syndrome and Exfoliation Glaucoma?
Abstract
The multifunctional protein clusterin (CLU) is a secreted glycoprotein ubiquitously expressed throughout the body, including in the eye. Its primary function is to act as an extracellular molecular chaperone, preventing the precipitation and aggregation of misfolded extracellular proteins. Clusterin is commonly identified at fluid-tissue interfaces, and has been identified in most body fluids. It is a component of exfoliation material, and CLU mRNA is reduced in eyes with exfoliation syndrome compared with controls. SNPs located in the CLU genomic region have been associated with Alzheimer disease (AD) at the genome-wide level and several CLU SNPs located in an apparent regulatory region have been nominally associated with XFS/XFG in Caucasians with European ancestry and in south Indians. Interestingly, clusterin associates with altered elastic fibers in human photoaged skin and prevents UV-induced elastin aggregation in vitro. In light of the known geographic risk factors for XFS/XFG, which could include UV light, investigations of CLU-geographic interactions could be of interest. Future studies investigating rare CLU variation and other complex interactions including gene-gene interactions in XFS/XFG cases and controls may also be fruitful. Although CLU has been considered as a therapeutic target in AD, cancer and dry eye, a role for clusterin in XFS/XFG needs to be better defined before therapeutic approaches involving CLU can be entertained.
Conflict of interest statement
Figures


Similar articles
-
Association of clusterin (CLU) variants and exfoliation syndrome: An analysis in two Caucasian studies and a meta-analysis.Exp Eye Res. 2015 Oct;139:115-22. doi: 10.1016/j.exer.2015.08.004. Epub 2015 Aug 10. Exp Eye Res. 2015. PMID: 26272660 Free PMC article. Review.
-
Exfoliation Syndrome: A Disease of Autophagy and LOXL1 Proteopathy.J Glaucoma. 2018 Jul;27 Suppl 1(Suppl 1):S44-S53. doi: 10.1097/IJG.0000000000000919. J Glaucoma. 2018. PMID: 29547474 Free PMC article. Review.
-
Clusterin deficiency in eyes with pseudoexfoliation syndrome may be implicated in the aggregation and deposition of pseudoexfoliative material.Invest Ophthalmol Vis Sci. 2006 May;47(5):1982-90. doi: 10.1167/iovs.05-1580. Invest Ophthalmol Vis Sci. 2006. PMID: 16639006
-
Compositional Analysis of Extracellular Aggregates in the Eyes of Patients With Exfoliation Syndrome and Exfoliation Glaucoma.Invest Ophthalmol Vis Sci. 2021 Dec 1;62(15):27. doi: 10.1167/iovs.62.15.27. Invest Ophthalmol Vis Sci. 2021. PMID: 34964803 Free PMC article.
-
The management of exfoliative glaucoma.Prog Brain Res. 2008;173:211-24. doi: 10.1016/S0079-6123(08)01115-1. Prog Brain Res. 2008. PMID: 18929111
Cited by
-
The normalizing effects of the CYP46A1 activator efavirenz on retinal sterol levels and risk factors for glaucoma in Apoj-/- mice.Cell Mol Life Sci. 2023 Jul 1;80(7):194. doi: 10.1007/s00018-023-04848-y. Cell Mol Life Sci. 2023. PMID: 37392222 Free PMC article.
-
Therapeutic Potential of the Molecular Chaperone and Matrix Metalloproteinase Inhibitor Clusterin for Dry Eye.Int J Mol Sci. 2020 Dec 24;22(1):116. doi: 10.3390/ijms22010116. Int J Mol Sci. 2020. PMID: 33374364 Free PMC article. Review.
-
Nailfold Capillaroscopy of Resting Peripheral Blood Flow in Exfoliation Glaucoma and Primary Open-Angle Glaucoma.JAMA Ophthalmol. 2019 Jun 1;137(6):618-625. doi: 10.1001/jamaophthalmol.2019.0434. JAMA Ophthalmol. 2019. PMID: 30973595 Free PMC article.
-
Macula Vessel Density and Foveal Avascular Zone Parameters in Exfoliation Glaucoma Compared to Primary Open-Angle Glaucoma.Invest Ophthalmol Vis Sci. 2019 Mar 1;60(4):1244-1253. doi: 10.1167/iovs.18-25986. Invest Ophthalmol Vis Sci. 2019. PMID: 30924849 Free PMC article.
-
Histopathological Analysis of Pseudoexfoliation Material in Ocular Surgeries: Clinical Implications.Diagnostics (Basel). 2024 Sep 30;14(19):2187. doi: 10.3390/diagnostics14192187. Diagnostics (Basel). 2024. PMID: 39410590 Free PMC article.
References
-
- Sein J, Galor A, Sheth A, Kruh J, Pasquale LR, Karp CL. Exfoliation syndrome: new genetic and pathophysiologic insights. Curr Opin Ophthalmol. 2013. March;24(2):167–74. - PubMed
-
- Thorleifsson G, Magnusson KP, Sulem P, Walters GB, Gudbjartsson DF, Stefansson H, Jonsson T, Jonasdottir A, Jonasdottir A, Stefansdottir G, Masson G, Hardarson GA, Petursson H, Arnarsson A, Motallebipour M, Wallerman O, Wadelius C, Gulcher JR, Thorsteinsdottir U, Kong A, Jonasson F, Stefansson K. Common sequence variants in the LOXL1 gene confer susceptibility to exfoliation glaucoma. Science. 2007;317:1397–1400. - PubMed
-
- Fingert JH, Alward WL, Kwon YH, Wang K, Streb LM, Sheffield VC, Stone EM. LOXL1 mutations are associated with exfoliation syndrome in patients from the midwestern United States. Am. J. Ophthalmol. 2007;144:974–975. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous